Axsome Therapeutics (AXSM) Net Cash Flow Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -33.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.71% |
| Dec 31, 2025 | 55.58% |
| Sep 30, 2025 | -47.54% |
| Jun 30, 2025 | 29.79% |
| Mar 31, 2025 | -101.51% |
| Dec 31, 2024 | 24.76% |
| Sep 30, 2024 | 34.61% |
| Jun 30, 2024 | 12.35% |
| Mar 31, 2024 | -41.77% |
| Dec 31, 2023 | -18.00% |
| Sep 30, 2023 | -55.49% |
| Jun 30, 2023 | 213.26% |
| Mar 31, 2023 | 58.95% |
| Dec 31, 2022 | -29.09% |
| Sep 30, 2022 | 158.35% |
| Jun 30, 2022 | -44.47% |
| Mar 31, 2022 | -27.27% |
| Dec 31, 2021 | -182.24% |
| Sep 30, 2021 | -73.07% |
| Jun 30, 2021 | -55.11% |
| Mar 31, 2021 | -37.52% |
| Dec 31, 2020 | -114.53% |
| Sep 30, 2020 | 56.70% |
| Jun 30, 2020 | 1.90% |
| Mar 31, 2020 | -67.46% |
| Dec 31, 2019 | 301.19% |
| Sep 30, 2019 | -27.50% |
| Jun 30, 2019 | 59.94% |
| Mar 31, 2019 | 109.84% |
| Dec 31, 2018 | -26.59% |
| Sep 30, 2018 | -41.96% |
| Jun 30, 2018 | -49.33% |
| Mar 31, 2018 | -99.72% |